𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features

✍ Scribed by Ugo De Giorgi; Giovanni Rosti; Roberto Salvioni; Giorgio Papiani; Michela Ballardini; Giorgio Pizzocaro; Maurizio Marangolo

Book ID
116956550
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
524 KB
Volume
29
Category
Article
ISSN
1078-1439

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Salvage high-dose chemotherapy in patien
Salvage high-dose chemotherapy in patients with germ cell tumors : An Italian experience with 84 patients
✍ Giovanni Rosti; Ugo De Giorgi; Roberto Salvioni; Giorgio Papiani; Loretta Sebast πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 85 KB

## Abstract ## BACKGROUND High‐dose chemotherapy (HDCT) followed by hematopoietic stem cell support (HSCS) potentially may be curative in patients with germ cell tumor (GCT) who develop recurrent tumors or who have an inadequate response after receiving standard‐dose chemotherapy. The authors repo

VAB-5 combination chemotherapy in progno
VAB-5 combination chemotherapy in prognostically poor risk patients with germ cell tumors
✍ Davor Vugrin; Willet F. Whitmore; Robert B. Golbey πŸ“‚ Article πŸ“… 1983 πŸ› John Wiley and Sons 🌐 English βš– 429 KB πŸ‘ 2 views

Forty-four patients with nonseminomatous germ cell tumors with "poor prognostic features" were entered on the VAB-5 regimen and 38 are evaluable. VAB-5 represents an intensified version of the VAB-4 protocol. Poor prognostic features were considered to be bulky metastases (>5 cm in diameter), palpab